Trials / Withdrawn
WithdrawnNCT02328625
Scleroderma Treatment With Celution Processed ADRCs Registry
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Cytori Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This registry study will assess the safety and performance of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in the treatment of hand scleroderma.
Detailed description
This registry study will assess the safety and performance of the Celution System in preparation of adipose derived regenerative cells in the treatment of scleroderma affecting the hands. This will be a multi-center, multi-national study.
Conditions
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-08-01
- Completion
- 2017-06-01
- First posted
- 2014-12-31
- Last updated
- 2016-03-17
Source: ClinicalTrials.gov record NCT02328625. Inclusion in this directory is not an endorsement.